Toxicity and Outcome following High Dose Chemotherapy and Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma

被引：0
|
作者：
Lemieux, Christopher [1 ]
Laroche, Vincent [1 ]
Cantin, Guy [1 ]
Cote, Julie [1 ]
Demers, Christine [1 ]
Gallagher, Genevieve [1 ]
机构：
[1] Univ Laval, CHU Quebec, Hop Enfant Jesus, Div Hematol & Med Oncol,Dept Med, Ville De Quebec, PQ, Canada
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P686
引用
收藏
页码：658 / 659
页数：2
相关论文
共 50 条
  • [41] Measures of immune recovery following autologous stem cell transplantation for multiple myeloma and outcome
    Hegerova, Livia
    Gertz, Morie
    Lacy, Martha
    Dispenzieri, Angela
    Buadi, Francis
    Hayman, Suzanne R.
    Dingli, David
    Porrata, Luis F.
    Kumar, Shaji
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] Cardiac Toxicity After High-Dose Melphlan and Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
    Gul, Zartash
    Bashir, Qaiser
    Nieto, Yago
    Sherwani, Nazeer
    Parmar, Simrit
    Shah, Nina
    Dinh, Yvonne T.
    Hosing, Chitra M.
    Popat, Uday R.
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Giralt, Sergio A.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BLOOD, 2012, 120 (21)
  • [43] High dose chemotherapy and autologous stem cell transplantation in multiple myeloma: Comparison of four preparative regimens.
    Alessandrino, EP
    Bragotti, LZ
    Colombo, AA
    Algarotti, A
    Bernasconi, P
    Maffioli, M
    Caldera, D
    Corso, A
    Rumi, E
    Troletti, D
    Lazzarino, M
    BLOOD, 2005, 106 (11) : 460B - 460B
  • [44] Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma
    Hagen, Patrick
    Norton, Joseph
    Tsai, Stephanie
    Campo, Loredana
    Lee, Mary
    Gomez, Kayeromi
    Stiff, Patrick
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1422 - 1428
  • [45] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma
    Murakami, H
    Fujii, H
    Inaba, T
    Shimazaki, C
    Okamoto, S
    Miwa, A
    Sawamura, M
    Abe, M
    Chou, T
    Asaoku, H
    Kitahara, Y
    Hayashi, K
    Kosaka, M
    Togawa, A
    Takatsuki, K
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (03) : 169 - 173
  • [46] High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: experience from a developing country
    Bekadja, M. A.
    Osmani, S.
    Talhi, S.
    Brahimi, M.
    Bekadja, S.
    Entasoltan, B.
    Yafour, N.
    Arabi, A.
    Bouhass, R.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S329 - S330
  • [47] High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma
    Maisnar, V.
    Hajek, R.
    Scudla, V.
    Gregora, E.
    Buchler, T.
    Tichy, M.
    Kotoucek, P.
    Kafkova, A.
    Forraiova, L.
    Minarik, J.
    Radocha, J.
    Blaha, V.
    Maly, J.
    BONE MARROW TRANSPLANTATION, 2008, 41 (01) : 51 - 54
  • [48] High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma
    V Maisnar
    R Hájek
    V Ščudla
    E Gregora
    T Büchler
    M Tichý
    P Kotouček
    A Kafková
    L Forraiová
    J Minařík
    J Radocha
    V Bláha
    J Malý
    Bone Marrow Transplantation, 2008, 41 : 51 - 54
  • [49] High-dose chemotherapy with hematopoietic stem cell transplantation for patients with advanced multiple myeloma
    Einsele, H
    Straka, C
    Emmerich, B
    Bamberg, M
    Budach, W
    ONKOLOGIE, 2000, 23 (03): : 272 - 274
  • [50] Incidence Of Hypotension In Patients With Multiple Myeloma During High Dose Chemotherapy and Autologous Stem Cell Rescue
    Sehgal, Priya
    Biran, Noa
    Sahni, Gagan
    Chari, Ajai
    BLOOD, 2013, 122 (21)
12345